Back to Search Start Over

Femara Approved as Adjuvant Rx for Early Breast Cancer

Source :
Oncology News International. Feb 1, 2006, 7
Publication Year :
2006

Abstract

ROCKVILLE, Maryland-Femara (letrozole, Novartis) has received FDA approval for use in treating early breast cancer in postmenopausal women following surgery. The agency based its approval on findings from the BIG [...]

Subjects

Subjects :
Postmenopausal women -- Diseases
Breast cancer -- Drug therapy
Antimitotic agents -- Health aspects
Antineoplastic agents -- Health aspects
Health
Femara (Medication) -- Licensing, certification and accreditation

Details

Language :
English
ISSN :
10652957
Database :
Gale General OneFile
Journal :
Oncology News International
Publication Type :
Periodical
Accession number :
edsgcl.142723179

Tools

Authors Abstract Subjects Details